A simple outpatient treatment with oral Ifosfamide and oral Etoposide for patients with small cell lung cancer (SCLC) View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

1989-08

AUTHORS

T Cerny, M Lind, N Thatcher, R Swindell, R Stout

ABSTRACT

For the first time in a clinical study oral Ifosfamide was used: 65 elderly or unfit patients with small cell lung cancer (SCLC) were treated as outpatients with fractionated oral Ifosfamide and Etoposide. Forty patients (62%) had extensive stage (ED) disease. The median age of the patients was 66 years. In the 60 patients evaluable for response the objective response rate was 90% with a complete response (CR) rate of 32% and a partial response (PR) rate of 58%. The overall median survival of all 65 patients was 11 months (13 months for LD, 9.5 months for ED). In those patients with LD achieving a CR or a PR radiotherapy was given to the mediastinum. No prophylactic cranial irradiation was given. There was a rapid improvement in the responding patients' performance status and symptoms generally with the first treatment cycle. Overall haematological toxicity was mild, with intravenous antibiotics only being required in 4% of the courses and with only one treatment-related death from septicaemia. A higher than expected rate of CNS toxicity was seen (30%). This was generally mild and always fully reversible and consisted mainly of forgetfulness, occasionally hallucinations, nightmares and somnolence. In only one case did encephalopathy necessitate early termination of treatment. This raises the question of whether Ifosfamide metabolism differs quantitatively or qualitatively when given by the oral route as opposed to the usual intravenous route. We conclude that this simple outpatient based treatment gives a high response rate with rapid improvement in symptoms. More... »

PAGES

258

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1038/bjc.1989.265

DOI

http://dx.doi.org/10.1038/bjc.1989.265

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1028449904

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/2548560


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Oncology and Carcinogenesis", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Administration, Oral", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ambulatory Care", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antineoplastic Combined Chemotherapy Protocols", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Carcinoma, Small Cell", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Etoposide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Ifosfamide", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Lung Neoplasms", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Prospective Studies", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Christie Hospital NHS Foundation Trust", 
          "id": "https://www.grid.ac/institutes/grid.412917.8", 
          "name": [
            "CRC Department of Medical Oncology, Christie Hospital and Holt Radium Institute, Manchester, UK."
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cerny", 
        "givenName": "T", 
        "id": "sg:person.01145564236.77", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01145564236.77"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Lind", 
        "givenName": "M", 
        "id": "sg:person.010312366332.17", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010312366332.17"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Thatcher", 
        "givenName": "N", 
        "id": "sg:person.015365270024.60", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015365270024.60"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Swindell", 
        "givenName": "R", 
        "id": "sg:person.01215060163.78", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01215060163.78"
        ], 
        "type": "Person"
      }, 
      {
        "familyName": "Stout", 
        "givenName": "R", 
        "id": "sg:person.01364462322.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01364462322.31"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1016/0305-7372(85)90011-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001184954"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00273399", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006457921", 
          "https://doi.org/10.1007/bf00273399"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00273399", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006457921", 
          "https://doi.org/10.1007/bf00273399"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/1097-0142(19871115)60:10<2382::aid-cncr2820601006>3.0.co;2-v", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011961750"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0360-3016(84)90032-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014623085"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.296.6630.1145", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028631379"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/1097-0142(19840915)54:1+<1193::aid-cncr2820541317>3.0.co;2-z", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030294313"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/ijc.2910390204", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031844483"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0277-5379(82)90143-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033699183"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00256688", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038158593", 
          "https://doi.org/10.1007/bf00256688"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/bf00256688", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1038158593", 
          "https://doi.org/10.1007/bf00256688"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/0277-5379(88)90239-8", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049349979"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079493765", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079510578", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079777150", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079921453", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079934056", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "1989-08", 
    "datePublishedReg": "1989-08-01", 
    "description": "For the first time in a clinical study oral Ifosfamide was used: 65 elderly or unfit patients with small cell lung cancer (SCLC) were treated as outpatients with fractionated oral Ifosfamide and Etoposide. Forty patients (62%) had extensive stage (ED) disease. The median age of the patients was 66 years. In the 60 patients evaluable for response the objective response rate was 90% with a complete response (CR) rate of 32% and a partial response (PR) rate of 58%. The overall median survival of all 65 patients was 11 months (13 months for LD, 9.5 months for ED). In those patients with LD achieving a CR or a PR radiotherapy was given to the mediastinum. No prophylactic cranial irradiation was given. There was a rapid improvement in the responding patients' performance status and symptoms generally with the first treatment cycle. Overall haematological toxicity was mild, with intravenous antibiotics only being required in 4% of the courses and with only one treatment-related death from septicaemia. A higher than expected rate of CNS toxicity was seen (30%). This was generally mild and always fully reversible and consisted mainly of forgetfulness, occasionally hallucinations, nightmares and somnolence. In only one case did encephalopathy necessitate early termination of treatment. This raises the question of whether Ifosfamide metabolism differs quantitatively or qualitatively when given by the oral route as opposed to the usual intravenous route. We conclude that this simple outpatient based treatment gives a high response rate with rapid improvement in symptoms.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1038/bjc.1989.265", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1017082", 
        "issn": [
          "0007-0920", 
          "1532-1827"
        ], 
        "name": "British Journal of Cancer", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "2", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "60"
      }
    ], 
    "name": "A simple outpatient treatment with oral Ifosfamide and oral Etoposide for patients with small cell lung cancer (SCLC)", 
    "pagination": "258", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "878714c4852049badb395cc1bf1dbcb1008bca77093970b1a231aa154ba4aa43"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "2548560"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "0370635"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1038/bjc.1989.265"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1028449904"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1038/bjc.1989.265", 
      "https://app.dimensions.ai/details/publication/pub.1028449904"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T11:56", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000359_0000000359/records_29216_00000001.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://www.nature.com/articles/bjc1989265"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1038/bjc.1989.265'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1038/bjc.1989.265'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1038/bjc.1989.265'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1038/bjc.1989.265'


 

This table displays all metadata directly associated to this object as RDF triples.

195 TRIPLES      21 PREDICATES      59 URIs      36 LITERALS      24 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1038/bjc.1989.265 schema:about N0f25db82edbe4e2e9aac057e4e0dfa4d
2 N24143a1c20694b46b6661aa2519c0915
3 N3ac6639d40b84ff797d4d9ced23bf7fd
4 N3efe2f5e000d4c2aaeef219b3d191cee
5 N4406cf1e3dd5422a8ecdd6142d1e2ac4
6 N482b3d7274cd402e89515e9e13408fdb
7 N7f003cd2b3884149b1ae2d13b7365ef8
8 N80ee9eecf09e470bab1dd8f04958badd
9 N8e44d38439f245469d16b76c115a24d8
10 N8f0a4ebcd8c94043822273121cb40a44
11 N9bf8a796e54147c886c76a65bac3d2a2
12 Nc5394d731bf14196bb3218bb2291da23
13 Nd3a97a9916824a6f961e06a58cc5d019
14 Ne7905efccc1247918a2ac2b824beaf0b
15 Ned8d32435ed34cfb8ddb704d721ab713
16 anzsrc-for:11
17 anzsrc-for:1112
18 schema:author Nc4c284c34ca240c4ac87097f04267c7d
19 schema:citation sg:pub.10.1007/bf00256688
20 sg:pub.10.1007/bf00273399
21 https://app.dimensions.ai/details/publication/pub.1079493765
22 https://app.dimensions.ai/details/publication/pub.1079510578
23 https://app.dimensions.ai/details/publication/pub.1079777150
24 https://app.dimensions.ai/details/publication/pub.1079921453
25 https://app.dimensions.ai/details/publication/pub.1079934056
26 https://doi.org/10.1002/1097-0142(19840915)54:1+<1193::aid-cncr2820541317>3.0.co;2-z
27 https://doi.org/10.1002/1097-0142(19871115)60:10<2382::aid-cncr2820601006>3.0.co;2-v
28 https://doi.org/10.1002/ijc.2910390204
29 https://doi.org/10.1016/0277-5379(82)90143-2
30 https://doi.org/10.1016/0277-5379(88)90239-8
31 https://doi.org/10.1016/0305-7372(85)90011-8
32 https://doi.org/10.1016/0360-3016(84)90032-4
33 https://doi.org/10.1136/bmj.296.6630.1145
34 schema:datePublished 1989-08
35 schema:datePublishedReg 1989-08-01
36 schema:description For the first time in a clinical study oral Ifosfamide was used: 65 elderly or unfit patients with small cell lung cancer (SCLC) were treated as outpatients with fractionated oral Ifosfamide and Etoposide. Forty patients (62%) had extensive stage (ED) disease. The median age of the patients was 66 years. In the 60 patients evaluable for response the objective response rate was 90% with a complete response (CR) rate of 32% and a partial response (PR) rate of 58%. The overall median survival of all 65 patients was 11 months (13 months for LD, 9.5 months for ED). In those patients with LD achieving a CR or a PR radiotherapy was given to the mediastinum. No prophylactic cranial irradiation was given. There was a rapid improvement in the responding patients' performance status and symptoms generally with the first treatment cycle. Overall haematological toxicity was mild, with intravenous antibiotics only being required in 4% of the courses and with only one treatment-related death from septicaemia. A higher than expected rate of CNS toxicity was seen (30%). This was generally mild and always fully reversible and consisted mainly of forgetfulness, occasionally hallucinations, nightmares and somnolence. In only one case did encephalopathy necessitate early termination of treatment. This raises the question of whether Ifosfamide metabolism differs quantitatively or qualitatively when given by the oral route as opposed to the usual intravenous route. We conclude that this simple outpatient based treatment gives a high response rate with rapid improvement in symptoms.
37 schema:genre research_article
38 schema:inLanguage en
39 schema:isAccessibleForFree true
40 schema:isPartOf N3d249bc0eda7436c9d7e5261d959c5e0
41 N889af43d9d264d2296ac2977564c07fa
42 sg:journal.1017082
43 schema:name A simple outpatient treatment with oral Ifosfamide and oral Etoposide for patients with small cell lung cancer (SCLC)
44 schema:pagination 258
45 schema:productId N0ea2842aa61042699d237252ce9c3edc
46 N2aae460e99c542cd8f6cb2b5f97532e7
47 N340048e72f6c4b1abd7b3fc830f2f821
48 N52ff5fccba7842369933fb2a21b924d4
49 Nbb6fad9b65544e0b9c9e760f8c33424f
50 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028449904
51 https://doi.org/10.1038/bjc.1989.265
52 schema:sdDatePublished 2019-04-11T11:56
53 schema:sdLicense https://scigraph.springernature.com/explorer/license/
54 schema:sdPublisher Ne48de3bf9cfe474f80a2c10edacafe7f
55 schema:url https://www.nature.com/articles/bjc1989265
56 sgo:license sg:explorer/license/
57 sgo:sdDataset articles
58 rdf:type schema:ScholarlyArticle
59 N0ea2842aa61042699d237252ce9c3edc schema:name doi
60 schema:value 10.1038/bjc.1989.265
61 rdf:type schema:PropertyValue
62 N0f25db82edbe4e2e9aac057e4e0dfa4d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
63 schema:name Etoposide
64 rdf:type schema:DefinedTerm
65 N24143a1c20694b46b6661aa2519c0915 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
66 schema:name Aged, 80 and over
67 rdf:type schema:DefinedTerm
68 N2aae460e99c542cd8f6cb2b5f97532e7 schema:name pubmed_id
69 schema:value 2548560
70 rdf:type schema:PropertyValue
71 N340048e72f6c4b1abd7b3fc830f2f821 schema:name nlm_unique_id
72 schema:value 0370635
73 rdf:type schema:PropertyValue
74 N3ac6639d40b84ff797d4d9ced23bf7fd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
75 schema:name Prospective Studies
76 rdf:type schema:DefinedTerm
77 N3d249bc0eda7436c9d7e5261d959c5e0 schema:issueNumber 2
78 rdf:type schema:PublicationIssue
79 N3efe2f5e000d4c2aaeef219b3d191cee schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
80 schema:name Aged
81 rdf:type schema:DefinedTerm
82 N4012e2803f4f44559a6e6beb4bad5a9f rdf:first sg:person.01364462322.31
83 rdf:rest rdf:nil
84 N4406cf1e3dd5422a8ecdd6142d1e2ac4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
85 schema:name Adult
86 rdf:type schema:DefinedTerm
87 N482b3d7274cd402e89515e9e13408fdb schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
88 schema:name Middle Aged
89 rdf:type schema:DefinedTerm
90 N52ff5fccba7842369933fb2a21b924d4 schema:name dimensions_id
91 schema:value pub.1028449904
92 rdf:type schema:PropertyValue
93 N7f003cd2b3884149b1ae2d13b7365ef8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Ambulatory Care
95 rdf:type schema:DefinedTerm
96 N80ee9eecf09e470bab1dd8f04958badd schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Female
98 rdf:type schema:DefinedTerm
99 N889af43d9d264d2296ac2977564c07fa schema:volumeNumber 60
100 rdf:type schema:PublicationVolume
101 N8e44d38439f245469d16b76c115a24d8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
102 schema:name Humans
103 rdf:type schema:DefinedTerm
104 N8f0a4ebcd8c94043822273121cb40a44 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Antineoplastic Combined Chemotherapy Protocols
106 rdf:type schema:DefinedTerm
107 N93c70b18c7274f489a79280b4cb66437 rdf:first sg:person.010312366332.17
108 rdf:rest Nb5d21c68aaa348599dfbab5e707a4647
109 N9bf8a796e54147c886c76a65bac3d2a2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
110 schema:name Male
111 rdf:type schema:DefinedTerm
112 Nb5d21c68aaa348599dfbab5e707a4647 rdf:first sg:person.015365270024.60
113 rdf:rest Ne8c9d0bdee334e848eb76d850e1cb84d
114 Nbb6fad9b65544e0b9c9e760f8c33424f schema:name readcube_id
115 schema:value 878714c4852049badb395cc1bf1dbcb1008bca77093970b1a231aa154ba4aa43
116 rdf:type schema:PropertyValue
117 Nc4c284c34ca240c4ac87097f04267c7d rdf:first sg:person.01145564236.77
118 rdf:rest N93c70b18c7274f489a79280b4cb66437
119 Nc5394d731bf14196bb3218bb2291da23 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
120 schema:name Carcinoma, Small Cell
121 rdf:type schema:DefinedTerm
122 Nd3a97a9916824a6f961e06a58cc5d019 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name Administration, Oral
124 rdf:type schema:DefinedTerm
125 Ne48de3bf9cfe474f80a2c10edacafe7f schema:name Springer Nature - SN SciGraph project
126 rdf:type schema:Organization
127 Ne7905efccc1247918a2ac2b824beaf0b schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Ifosfamide
129 rdf:type schema:DefinedTerm
130 Ne8c9d0bdee334e848eb76d850e1cb84d rdf:first sg:person.01215060163.78
131 rdf:rest N4012e2803f4f44559a6e6beb4bad5a9f
132 Ned8d32435ed34cfb8ddb704d721ab713 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Lung Neoplasms
134 rdf:type schema:DefinedTerm
135 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
136 schema:name Medical and Health Sciences
137 rdf:type schema:DefinedTerm
138 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
139 schema:name Oncology and Carcinogenesis
140 rdf:type schema:DefinedTerm
141 sg:journal.1017082 schema:issn 0007-0920
142 1532-1827
143 schema:name British Journal of Cancer
144 rdf:type schema:Periodical
145 sg:person.010312366332.17 schema:familyName Lind
146 schema:givenName M
147 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010312366332.17
148 rdf:type schema:Person
149 sg:person.01145564236.77 schema:affiliation https://www.grid.ac/institutes/grid.412917.8
150 schema:familyName Cerny
151 schema:givenName T
152 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01145564236.77
153 rdf:type schema:Person
154 sg:person.01215060163.78 schema:familyName Swindell
155 schema:givenName R
156 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01215060163.78
157 rdf:type schema:Person
158 sg:person.01364462322.31 schema:familyName Stout
159 schema:givenName R
160 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01364462322.31
161 rdf:type schema:Person
162 sg:person.015365270024.60 schema:familyName Thatcher
163 schema:givenName N
164 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015365270024.60
165 rdf:type schema:Person
166 sg:pub.10.1007/bf00256688 schema:sameAs https://app.dimensions.ai/details/publication/pub.1038158593
167 https://doi.org/10.1007/bf00256688
168 rdf:type schema:CreativeWork
169 sg:pub.10.1007/bf00273399 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006457921
170 https://doi.org/10.1007/bf00273399
171 rdf:type schema:CreativeWork
172 https://app.dimensions.ai/details/publication/pub.1079493765 schema:CreativeWork
173 https://app.dimensions.ai/details/publication/pub.1079510578 schema:CreativeWork
174 https://app.dimensions.ai/details/publication/pub.1079777150 schema:CreativeWork
175 https://app.dimensions.ai/details/publication/pub.1079921453 schema:CreativeWork
176 https://app.dimensions.ai/details/publication/pub.1079934056 schema:CreativeWork
177 https://doi.org/10.1002/1097-0142(19840915)54:1+<1193::aid-cncr2820541317>3.0.co;2-z schema:sameAs https://app.dimensions.ai/details/publication/pub.1030294313
178 rdf:type schema:CreativeWork
179 https://doi.org/10.1002/1097-0142(19871115)60:10<2382::aid-cncr2820601006>3.0.co;2-v schema:sameAs https://app.dimensions.ai/details/publication/pub.1011961750
180 rdf:type schema:CreativeWork
181 https://doi.org/10.1002/ijc.2910390204 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031844483
182 rdf:type schema:CreativeWork
183 https://doi.org/10.1016/0277-5379(82)90143-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033699183
184 rdf:type schema:CreativeWork
185 https://doi.org/10.1016/0277-5379(88)90239-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049349979
186 rdf:type schema:CreativeWork
187 https://doi.org/10.1016/0305-7372(85)90011-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001184954
188 rdf:type schema:CreativeWork
189 https://doi.org/10.1016/0360-3016(84)90032-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014623085
190 rdf:type schema:CreativeWork
191 https://doi.org/10.1136/bmj.296.6630.1145 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028631379
192 rdf:type schema:CreativeWork
193 https://www.grid.ac/institutes/grid.412917.8 schema:alternateName Christie Hospital NHS Foundation Trust
194 schema:name CRC Department of Medical Oncology, Christie Hospital and Holt Radium Institute, Manchester, UK.
195 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...